M Flepp
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Braun D, Fehr J, Schmidt A, Nicca D, Kusejko K, Kouyos R, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Swiss HIV Cohort Study Group. Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Med 2019
Dec 18, 2019Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Dec 18, 2019HIV Med 2019
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H F, Braun D L, Fehr J, Schmidt A J, Nicca D, Kusejko K, Kouyos R D, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule Patrizia, Swiss HIV Cohort Study Group
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2012
Sep 24, 2012Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Sep 24, 2012HIV Med 2012
Weber R, the Swiss HIV Cohort Study (SHCS), Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza Pietro, Ledergerber B, Kowalska J, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Yerly S
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
Nov 22, 2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Nov 22, 2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Bertschy S, Furrer H, Christen A, Chave J, Flepp M, Schmid P, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71.
Jul 1, 2006Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Jul 1, 2006Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71
Bertschy S, Furrer H, Christen A, Chave J-P, Flepp M, Schmid Patrick, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J, Veuthey A, Battegay M, Telenti A, Flepp M, Vernazza P, Chave J, Rizzardi P, Vora S, Swiss HIV Cohort Study. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (London, England) 2001; 15:2287-92.
Nov 23, 2001Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Nov 23, 2001AIDS (London, England) 2001; 15:2287-92
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J P, Veuthey A L, Battegay M, Telenti A, Flepp M, Vernazza Pietro, Chave J P, Rizzardi P, Vora S, Swiss HIV Cohort Study
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study
Boubaker K, Francioli P, Rickenbach M, Opravil M, Egger M, Bernasconi E, Chave J, Boggian K, Hirschel B, Haensel A, Furrer H, Sudre P, Flepp M, Telenti A. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis 2001; 33:1931-7.
Oct 23, 2001Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study
Oct 23, 2001Clin Infect Dis 2001; 33:1931-7
Boubaker K, Francioli P, Rickenbach M, Opravil M, Egger M, Bernasconi E, Chave J P, Boggian Katia, Hirschel B, Haensel A, Furrer H, Sudre P, Flepp M, Telenti A
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza P, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:1322-7.
Oct 20, 2001Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Oct 20, 2001Lancet 2001; 358:1322-7
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza Pietro, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza P, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7.
Aug 11, 2001Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Aug 11, 2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza Pietro, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian K, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study. Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study. AIDS 2001; 15:501-7.
Mar 9, 2001Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Mar 9, 2001AIDS 2001; 15:501-7
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian Katia, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza P, Swiss HIV Cohort Study. Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients. HIV medicine 2001; 2:35-42.
Jan 1, 2001Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Jan 1, 2001HIV medicine 2001; 2:35-42
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza Pietro, Swiss HIV Cohort Study
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J, Boggian K, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-5.
Nov 25, 2000Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Nov 25, 2000Lancet 2000; 356:1800-5
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J C, Boggian Katia, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
Bürgisser P, Vernazza P, Flepp M, Böni J, Tomasik Z, Hummel U, Pantaleo G, Schüpbach J. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2000; 23:138-44.
Feb 1, 2000Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
Feb 1, 2000Journal of acquired immune deficiency syndromes (1999) 2000; 23:138-44
Bürgisser P, Vernazza Pietro, Flepp M, Böni J, Tomasik Z, Hummel U, Pantaleo G, Schüpbach J
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
Weber R, Meyenberger C, Opravil M, Kaiser L, Briner J, Spycher M, Pfyffer G, Altwegg M, Zbinden R, Ledergerber B, Flepp M. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Archives of internal medicine 1999; 159:1473-80.
Jul 12, 1999Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
Jul 12, 1999Archives of internal medicine 1999; 159:1473-80
Weber R, Meyenberger Christa, Opravil M, Kaiser L, Briner J, Spycher M A, Pfyffer G E, Altwegg M, Zbinden R, Ledergerber B, Flepp M
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study
Bassetti S, Bernasconi E, Vernazza P, Telenti A, Kaiser L, Flepp M, Rickenbach M, Furrer H, Battegay M, Sudre P. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 1999; 21:114-9.
Jun 1, 1999Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study
Jun 1, 1999Journal of acquired immune deficiency syndromes (1999) 1999; 21:114-9
Bassetti S, Bernasconi E, Vernazza Pietro, Telenti A, Kaiser L, Flepp M, Rickenbach M, Furrer H, Battegay M, Sudre P
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study
Furrer H, Flepp M, Rickenbach M, Vernazza P, Telenti A, Battegay M, Hirschel B, Bernasconi E, Opravil M, Egger M, Malinverni R. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. The New England journal of medicine 1999; 340:1301-6.
Apr 29, 1999Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study
Apr 29, 1999The New England journal of medicine 1999; 340:1301-6
Furrer H, Flepp M, Rickenbach M, Vernazza Pietro, Telenti A, Battegay M, Hirschel B, Bernasconi E, Opravil M, Egger M, Malinverni R
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study
Ledergerber B, Francioli P, Furrer H, Flepp M, Sudre P, Vernazza P, Battegay M, Hirschel B, Telenti A, Opravil M, Egger M, Weber R. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999; 353:863-8.
Mar 13, 1999Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study
Mar 13, 1999Lancet 1999; 353:863-8
Ledergerber B, Francioli P, Furrer H, Flepp M, Sudre P, Vernazza Pietro, Battegay M, Hirschel B, Telenti A, Opravil M, Egger M, Weber R